List view / Grid view

Neurodegenerative disease

 

news

$3 million grant given for ALS trials

21 July 2016 | By Niamh Louise Marriott, Digitial Content Producer

Almost $3 million in funding to support a Phase II trial of a new therapeutic approach, developed by Amylyx, for the treatment of ALS...